See more : FRMO Corporation (FRMO) Income Statement Analysis – Financial Results
Complete financial analysis of Global Hemp Group Inc. (GHG.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Global Hemp Group Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Power REIT (PW) Income Statement Analysis – Financial Results
- Reinvent Technology Partners (RTP) Income Statement Analysis – Financial Results
- Caster Co.Ltd. (9331.T) Income Statement Analysis – Financial Results
- Excelsior Biopharma Inc. (6496.TWO) Income Statement Analysis – Financial Results
- HSS Hire Group plc (HSS.L) Income Statement Analysis – Financial Results
Global Hemp Group Inc. (GHG.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://globalhempgroup.com
About Global Hemp Group Inc.
Global Hemp Group Inc. engages in the production and processing of industrial hemp in the United States. It focuses on the development of sustainable and green value-added industrial hemp products utilizing the processing of the hemp plant for multi-merchantable applications. The company was formerly known as Arris Holdings Inc. and changed its name to Global Hemp Group Inc. in March 2014. Global Hemp Group Inc. was incorporated in 2009 and is headquartered in North Vancouver, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 28.88K | 2.59K | 0.00 | 0.00 | 0.00 | 11.83K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 41.27K | 7.87K | 641.00 | 4.77K | 0.00 | 0.00 | 11.47K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | -41.27K | 21.01K | 1.95K | -4.77K | 0.00 | 0.00 | 367.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 72.75% | 75.23% | 0.00% | 0.00% | 0.00% | 3.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 17.96K | 26.18K | 29.18K | 39.07K | 4.23K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 483.83K | -253.43K | 2.62M | 673.54K | 2.43M | 262.37K | 417.22K | 62.89K | 313.27K | 807.36K | 36.20K | 63.32 | 137.94K | 84.57K |
| Selling & Marketing | 23.05K | 52.35K | 207.24K | 826.00 | 60.30K | 13.19K | 4.10K | 407.00 | 1.21K | 191.02K | 30.00 | 27.88 | 0.00 | 0.00 |
| SG&A | 551.71K | -201.08K | 2.82M | 674.36K | 2.49M | 1.26M | 792.54K | 65.97K | 314.49K | 2.46M | 66.20K | 91.20 | 137.94K | 84.57K |
| Other Expenses | 0.00 | -1.84K | 50.93K | 21.94K | 13.17K | 31.68K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 551.71K | -184.96K | 2.90M | 725.48K | 2.54M | 1.26M | 792.54K | 65.97K | 314.49K | 2.61M | 66.20K | 116.20 | 137.94K | 84.57K |
| Cost & Expenses | 551.71K | -184.96K | 2.90M | 733.35K | 2.54M | 1.27M | 792.54K | 65.97K | 325.95K | 2.61M | 66.20K | 116.20 | 137.94K | 84.57K |
| Interest Income | 0.00 | 659.09 | 184.27 | 979.00 | 5.22K | 7.87K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 534.67K | 659.09K | 184.27K | 4.27K | 4.41K | 3.68K | 23.39K | 28.73K | 22.42K | 74.74K | 0.00 | 0.00 | 0.00 | 302.00 |
| Depreciation & Amortization | 526.92K | 659.09K | 41.27K | 21.94K | 8.66K | 4.77K | 790.84K | 65.97K | 293.43 | 2.46M | 10.91K | 10.91 | -258.25K | -431.43K |
| EBITDA | -24.79K | -893.59K | -7.81M | -870.04K | -2.95M | -1.21M | 700.00 | 0.00 | -314.12K | 0.00 | -55.30K | -91.20 | -396.19K | -516.30K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | -4,029.52% | -95,834.27% | 0.00% | 0.00% | 0.00% | -2,654.60% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -551.71K | 1.88M | -2.91M | -1.19M | -2.49M | -1.27M | -792.54K | -65.97K | -336.54K | -2.46M | -66.20K | -102.10 | -137.94K | -84.87K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | -4,105.49% | -96,168.78% | 0.00% | 0.00% | 0.00% | -2,844.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -2.03M | -611.32K | -5.15M | -699.21K | -92.26K | -317.75K | -20.98K | 24.00 | -168.38K | -153.23K | 0.00 | -14.10 | -258.25K | -431.74K |
| Income Before Tax | -2.58M | -2.17M | -8.04M | -1.38M | -2.92M | -1.59M | -813.52K | -65.95K | -505.29K | -2.61M | -66.20K | -116.20 | -396.19K | -516.60K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | -4,772.88% | -112,763.25% | 0.00% | 0.00% | 0.00% | -4,270.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 1.69M | 187.37K | -586.21K | -197.26K | -287.80K | -790.83 | -65.97 | -22.42K | -153.23 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -2.58M | -3.86M | -8.23M | -792.01K | -2.72M | -1.57M | -813.52K | -65.95K | -482.86K | -2.61M | -66.20K | -116.20 | -396.19K | -516.60K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | -2,742.80% | -105,141.31% | 0.00% | 0.00% | 0.00% | -4,080.65% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.15 | -0.25 | -0.62 | -0.08 | -0.29 | -0.01 | -0.11 | -0.01 | 0.00 | -0.41 | -0.01 | -0.02 | 0.00 | -0.01 |
| EPS Diluted | -0.15 | -0.25 | -0.62 | -0.08 | -0.29 | -0.01 | -0.11 | -0.01 | 0.00 | -0.41 | -0.01 | -0.02 | 0.00 | -0.01 |
| Weighted Avg Shares Out | 17.47M | 15.52M | 13.29M | 9.44M | 9.34M | 173.18M | 7.41M | 7.06M | 137.92M | 6.36M | 5.76M | 5.40K | 104.36M | 51.12M |
| Weighted Avg Shares Out (Dil) | 17.47M | 15.52M | 13.29M | 9.44M | 9.34M | 173.18M | 7.41M | 7.06M | 137.92M | 6.36M | 5.76M | 5.40K | 104.36M | 51.12M |
Source: https://incomestatements.info
Category: Stock Reports